[HTML][HTML] Genetic polymorphism of the OPG gene associated with breast cancer
JT Ney, I Juhasz-Boess, F Gruenhage, S Graeber… - BMC cancer, 2013 - Springer
Background The receptor activator of NF-κB (RANK), its ligand (RANKL) and
osteoprotegerin (OPG) have been reported to play a role in the pathophysiological bone …
osteoprotegerin (OPG) have been reported to play a role in the pathophysiological bone …
Genetic polymorphism of the OPG gene associated with breast cancer
JT Ney, I Juhasz-Boess, F Gruenhage, S Graeber… - BMC cancer (Online …, 2013 - osti.gov
The receptor activator of NF-κB (RANK), its ligand (RANKL) and osteoprotegerin (OPG) have
been reported to play a role in the pathophysiological bone turnover and in the …
been reported to play a role in the pathophysiological bone turnover and in the …
[PDF][PDF] Genetic polymorphism of the OPG gene associated with breast cancer
JT Ney, I Juhasz-Boess, F Gruenhage, S Graeber… - 2013 - researchgate.net
Background: The receptor activator of NF-κB (RANK), its ligand (RANKL) and
osteoprotegerin (OPG) have been reported to play a role in the pathophysiological bone …
osteoprotegerin (OPG) have been reported to play a role in the pathophysiological bone …
Genetic polymorphism of the OPG gene associated with breast cancer
JT Ney, I Juhasz-Boess, F Gruenhage… - BMC …, 2013 - search.proquest.com
Background: The receptor activator of NF-κB (RANK), its ligand (RANKL) and
osteoprotegerin (OPG) have been reported to play a role in the pathophysiological bone …
osteoprotegerin (OPG) have been reported to play a role in the pathophysiological bone …
Genetic polymorphism of the OPG gene associated with breast cancer.
JT Ney, I Juhasz-Boess, F Gruenhage, S Graeber… - 2013 - cabidigitallibrary.org
Background: The receptor activator of NF-κB (RANK), its ligand (RANKL) and
osteoprotegerin (OPG) have been reported to play a role in the pathophysiological bone …
osteoprotegerin (OPG) have been reported to play a role in the pathophysiological bone …
[PDF][PDF] Genetic polymorphism of the OPG gene associated with breast cancer
JT Ney, I Juhasz-Boess, F Gruenhage, S Graeber… - 2013 - Citeseer
Background: The receptor activator of NF-κB (RANK), its ligand (RANKL) and
osteoprotegerin (OPG) have been reported to play a role in the pathophysiological bone …
osteoprotegerin (OPG) have been reported to play a role in the pathophysiological bone …
Genetic polymorphism of the OPG gene associated with breast cancer.
JT Ney, I Juhasz-Boess, F Gruenhage… - BMC …, 2013 - search.ebscohost.com
Background: The receptor activator of NF-κ? B (RANK), its ligand (RANKL) and
osteoprotegerin (OPG) have been reported to play a role in the pathophysiological bone …
osteoprotegerin (OPG) have been reported to play a role in the pathophysiological bone …
Genetic polymorphism of the OPG gene associated with breast cancer.
JT Ney, I Juhasz-Boess, F Gruenhage, S Graeber… - BMC Cancer, 2013 - europepmc.org
Background The receptor activator of NF-κB (RANK), its ligand (RANKL) and
osteoprotegerin (OPG) have been reported to play a role in the pathophysiological bone …
osteoprotegerin (OPG) have been reported to play a role in the pathophysiological bone …
[PDF][PDF] Genetic polymorphism of the OPG gene associated with breast cancer
JT Ney, I Juhasz-Boess, F Gruenhage, S Graeber… - 2013 - scienceopen.com
Background: The receptor activator of NF-κB (RANK), its ligand (RANKL) and
osteoprotegerin (OPG) have been reported to play a role in the pathophysiological bone …
osteoprotegerin (OPG) have been reported to play a role in the pathophysiological bone …
[PDF][PDF] Genetic polymorphism of the OPG gene associated with breast cancer
JT Ney, I Juhasz-Boess, F Gruenhage, S Graeber… - 2013 - uniklinikum-saarland.de
Background: The receptor activator of NF-κB (RANK), its ligand (RANKL) and
osteoprotegerin (OPG) have been reported to play a role in the pathophysiological bone …
osteoprotegerin (OPG) have been reported to play a role in the pathophysiological bone …